EUVIMEDEUVIMED entdecken
Fallbericht

Identification of the Novel HLA‐B*55:141 Allele in a Chinese Individual

Wenjing Yuan iD, Fang Wang, Nanying Chen iD, Wei Zhang, Faming Zhu iD

HLA · 2025

DOI: 10.1111/tan.70246 ↗

Kurz gefasst

Fallbericht in der Zeitschrift HLA, 2025. Verfasst von Wenjing Yuan und 4 weiteren Autor:innen. Beteiligte Einrichtung: HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China. Hauptthemen laut MEDLINE: Alleles, Exons, HLA-B Antigens, Polymorphism, Single Nucleotide. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben. Gefördert von: Science Research Foundation of Zhejiang Healthy Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HLA‐B*55:141 differs from HLA‐B*55:08 by a single nucleotide substitution at position 363 G>C in exon 3.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AllelesExonsHLA-B AntigensPolymorphism, Single NucleotideHumansBase SequenceChinaHistocompatibility TestingSequence AlignmentSequence Analysis, DNAEast Asian People

Stichwörter der Autor:innen

HLA‐B*55:141next‐generation sequencingnovel allele

Substanzen

HLA-B Antigens

Autor:innen und Institutionen

  • HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China.

ORCID-Profile: Wenjing Yuan, Nanying Chen, Faming Zhu

Förderung

  • Science Research Foundation of Zhejiang Healthy Bureau

Zitieren

APA

Yuan, W., Wang, F., Chen, N., Zhang, W., & Zhu, F. (2025). Identification of the Novel HLA‐B*55:141 Allele in a Chinese Individual. HLA. https://doi.org/10.1111/tan.70246

Vancouver

Yuan W, Wang F, Chen N, Zhang W, Zhu F. Identification of the Novel HLA‐B*55:141 Allele in a Chinese Individual. HLA. 2025. doi:10.1111/tan.70246

BibTeX
@article{Yuan2025,
  author = {Yuan, Wenjing and Wang, Fang and Chen, Nanying and Zhang, Wei and Zhu, Faming},
  title = {Identification of the Novel HLA‐B*55:141 Allele in a Chinese Individual},
  journal = {HLA},
  year = {2025},
  doi = {10.1111/tan.70246}
}
Kostenlos starten →